Phastar
Ping-Chung Chang is a highly experienced professional in biostatistics and programming, currently serving as Head of Business Transformation and China General Manager at Phastar since April 2022. Prior to this role, Ping-Chung held several significant positions at PPD from May 2015 to March 2022, including Executive Director and Senior Director for the Asia Pacific region. Ping-Chung's expertise encompasses a range of roles in statistical analysis and trial management throughout multiple organizations, including MannKind Corporation, GSK, PAREXEL, Allergan, and Boehringer Ingelheim. Education credentials include a Master of Science in Biomathmatics, Statistics from North Carolina State University and a Bachelor of Science in Biostatistics in Agriculture from National Taiwan University.
This person is not in any teams
This person is not in any offices
Phastar
Phastar is a specialist biometrics contract research organization offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal quality, inspired by 4,000 years accumulated technical experience across the company. Phastar is headquartered in London (UK) and North Carolina (US) and has 15 offices worldwide